HIV-Positive Status Disclosure in Patients in Care in Rural South Africa: Implications for Scaling Up Treatment and Prevention Interventions

AIDS and Behavior

Volumn 19, Issue 2, 2015, Pages 322-329

  Abdool Karim, Quarraisha ^a,b   Dellar, Rachael C ^a   Bearnot, Benjamin ^c,d   Werner, Lise ^b   Frohlich, Janet A ^b   Kharsany, Ayesha B M ^b   Abdool Karim, Salim S ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Department of Medicine   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anti retroviral therapy; HIV prevention; Rural South Africa; Status disclosure; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN; INCIDENCE; INTERPERSONAL COMMUNICATION; MALE; PROSPECTIVE STUDY; PSYCHOLOGY; RURAL POPULATION; SOCIOECONOMICS; SOUTH AFRICA; STATISTICS AND NUMERICAL DATA;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RURAL POPULATION; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TRUTH DISCLOSURE;

EID: 84925519349     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0951-4     Document Type: Article

References (16)

1. Ramadhani HO, Thielman NM, Landman KZ, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45(11):1492–8.
2. Wong LH, Rooyen HV, Modiba P, et al. Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr. 2009;50(2):215–22.
3. Nabilek Z. HIV stigma and disclosure. Can social support help? Posit Aware. 2009;20(5):37–8.
4. Stutterheim SE, Bos AE, Pryor JB, Brands R, Liebregts M, Schaalma HP. Psychological and social correlates of HIV status disclosure: the significance of stigma visibility. AIDS Educ Prev. 2011;23(4):382–92.
5. Young SD, Hlavka Z, Modiba P, et al. HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr. 2010;55(5):620–4.
6. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
7. Parsons JT, Schrimshaw EW, Bimbi DS, Wolitski RJ, Gomez CA, Halkitis PN. Consistent, inconsistent, and non-disclosure to casual sexual partners among HIV-seropositive gay and bisexual men. AIDS. 2005;19(1):S87–97.
8. Obermeyer CM, Baijal P, Pegurri E. Facilitating HIV disclosure across diverse settings: a review. Am J Public Health. 2011;101(6):1011–23.
9. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.
10. Ndiaye C, Boileau C, Zunzunegui MV, et al. Gender-related factors influencing HIV serostatus disclosure in patients receiving HAART in West Africa. World Health Popul. 2008;10(3):43–54.
11. WHO Department of Gender, Women and Health. Gender dimensions of HIV status disclosure to sexual partners: Rates, barriers and outcomes for women: A review paper 2003 [cited Sep 20 2014]. Available at: http://whqlibdoc.who.int/publications/2004/9241590734.pdf?ua=1.
12. Karim QA, Kharsany AB, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2011;40(4):922–30.
13. UNAIDS. Joint United Nations Programme on HIV/AIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013 [cited 2014 Aug 14]. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
14. Hallett TB, Baeten JM, Heffron R, et al. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011;8(11):e1001123.
15. World Health Organisation (WHO). Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples: Recommendations for a public health approach 2012 [cited Sep 20 2014]. Available at: http://apps.who.int/iris/bitstream/10665/44646/1/9789241501972_eng.pdf?ua=1.
16. Barnabas RV, Celum C. Bending the curve: maximising impact with focused HIV prevention. Lancet. 2014;384(9939):216–7.